AVDL vs RF
Avadel Pharmaceuticals PLC (AVDL) versus RF (RF) — a side-by-side from cached financials, not a winner call.
Avadel Pharmaceuticals PLC (AVDL) is a drug manufacturers - specialty & generic company listed on US.
RF (RF) common stock.
Latest reported AVDL revenue for 2024-12-31 was $169.1M. Net income was -$48.8M. Revenue was up 504.8% from 2023-12-31 to 2024-12-31. AVDL currently screens at market cap $968.5M.
RF does not have a complete income-statement cache yet.
AVDL currently screens at market cap $968.5M. RF currently screens at market cap $0.
Not investment advice. Open the AVDL and RF stock pages for the full models.
Not investment advice.